Novartis Sets Out On The Critical Path; Will Others Follow?
Executive Summary
Novartis' announcement of research collaborations with FDA is one of the first tangible outcomes of the agency's Critical Path initiative
You may also be interested in...
Novartis Proposes Two-Phase Drug Development Model, Staged Approval
Novartis is advocating a two-phase drug development paradigm based on "models of disease.
Novartis Proposes Two-Phase Drug Development Model, Staged Approval
Novartis is advocating a two-phase drug development paradigm based on "models of disease.
FDA To Provide Updates On Critical Path Opportunities List Projects
FDA will highlight the agency's involvement in Critical Path projects in the coming months, Deputy Commissioner for Operations Janet Woodcock said March 16